Duloxetine is an antidepressant, with a specific batch having been recalled due to the presence of potentially cancer-causing ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Submission Follows the Successful Completion of the Pivotal Human Clinical TrialFDA 510(k) Clearance Anticipated During the Second ...
The products were found to contain an undeclared allergen, which could be a risk for those with food allergies.
Nano-X Imaging's Nanox.ARC scanner received expanded FDA clearance, potentially boosting sales and deployments. See why I ...
It's a U.S. Food and Drug Administration rule that most Americans know little about, yet gives corporations the license to ...
Two more products have been added to a safety alert issued by the Food and Drug Administration (FDA) regarding supplements ...
In a commentary published in JAMA, experts at the Rutgers Institute for Nicotine & Tobacco Studies have issued a call to ...
233,003 bottles of duloxetine have been recalled due to potentially containing high levels of cancer-causing impurities.
Theradaptive, a privately held, clinical stage biologics company developing protein therapeutics for spine, orthopedics, soft ...